Increasing Human Neural Stem Cell Transplantation Dose Alters Oligodendroglial and Neuronal Differentiation after Spinal Cord Injury

Stem Cell Reports. 2017 Jun 6;8(6):1534-1548. doi: 10.1016/j.stemcr.2017.04.009. Epub 2017 May 4.

Abstract

Multipotent human central nervous system-derived neural stem cells transplanted at doses ranging from 10,000 (low) to 500,000 (very high) cells differentiated predominantly into the oligodendroglial lineage. However, while the number of engrafted cells increased linearly in relationship to increasing dose, the proportion of oligodendrocytic cells declined. Increasing dose resulted in a plateau of engraftment, enhanced neuronal differentiation, and increased distal migration caudal to the transplantation sites. Dose had no effect on terminal sensory recovery or open-field locomotor scores. However, total human cell number and decreased oligodendroglial proportion were correlated with hindlimb girdle coupling errors. Conversely, greater oligodendroglial proportion was correlated with increased Ab step pattern, decreased swing speed, and increased paw intensity, consistent with improved recovery. These data suggest that transplant dose, and/or target niche parameters can regulate donor cell engraftment, differentiation/maturation, and lineage-specific migration profiles.

Keywords: cell dose; differentiation; fate; human neural stem cell; microenvironment; migration; spinal cord injury; stem cell niche dynamics; stem cell transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antigens, Nuclear / metabolism
  • Cell Differentiation*
  • Cell Lineage
  • Cell Movement
  • Cells, Cultured
  • Cellular Microenvironment
  • Gene Expression
  • Humans
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Microtubule-Associated Proteins / metabolism
  • Nerve Tissue Proteins / metabolism
  • Neural Stem Cells / cytology
  • Neural Stem Cells / metabolism
  • Neural Stem Cells / transplantation*
  • Neurons / cytology*
  • Neurons / metabolism
  • Oligodendrocyte Transcription Factor 2 / metabolism
  • Oligodendroglia / cytology*
  • Oligodendroglia / metabolism
  • Recovery of Function
  • Spinal Cord Injuries / therapy*
  • Stem Cell Niche

Substances

  • ARTN protein, human
  • Antigens, Nuclear
  • MAP2 protein, human
  • Microtubule-Associated Proteins
  • Nerve Tissue Proteins
  • OLIG2 protein, human
  • Oligodendrocyte Transcription Factor 2
  • neuronal nuclear antigen NeuN, human